SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): January 28, 2004
AMERICAN BIO MEDICA CORPORATION
---------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
New York 0-28666 14-1702188
------------------------------ ----------------------- -------------------
(State or Other Jurisdiction of (Commission File Number) (IRS Employer
Incorporation) Identification Number)
122 Smith Road, Kinderhook, NY 12106
---------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (800) 227-1243
ITEM 5. OTHER MATTERS
On January 28, 2004, the Registrant appointed Daniel W. Kollin to its
Board of Directors. Mr. Kollin was also appointed to the Registrant's Audit
Committee.
On January 28, 2004 the Registrant's Board of Directors accepted the
resignation of Dr. Gerald W. Lynch from the Registrant's Board of Directors. Dr.
Lynch also served on the Registrant's Audit and Compensation Committees. The
Registrant is unaware of any disagreement Dr. Lynch has with the Registrant on
any matter relating to the Registrant's operations, policies or practices, nor
has Dr. Lynch provided a letter outlining any such disagreements.
On January 30, 2004, the Registrant's Board of Directors announced the
resignation of Douglas Casterlin from the position of Executive Vice President
of Operations.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits.
The following exhibits are filed with this report on Form 8-K:
99.1 American Bio Medica Corporation press release dated
January 30, 2004.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AMERICAN BIO MEDICA CORPORATION (Registrant)
Dated: January 30, 2004 By: /s/ Keith E. Palmer
-----------------------------------------
Keith E. Palmer
Chief Financial Officer
Exhibit Index
Exhibit No. Description Page No.
----------- ----------- --------
99.1 American Bio Medica Corporation press 5
release dated January 30. 2004.